HOME
• how does remeron help ptsd
• remeron and panic attacks
• electric ground wrap remeron
• paroxetine remeron

remeron with prozac

If you remeron with prozac any of these other conditions, your doctor may need to adjust the dose of Remeron or order special tests: liver or kidney disease; bipolar disorder (manic depression); seizures or epilepsy; low blood pressure or dizzy spells; high cholesterol or triglycerides; heart disease, including angina (chest pain); a history of heart attack or stroke; or a history of drug abuse or suicidal thoughts. Special information if you are pregnant or breastfeeding The effects of Remeron during pregnancy have not been adequately studied. Do remeron with prozac use Remeron if you have used an MAO inhibitor within the past 14 days. The effectiveness of RemeronSolTab in hospitalized depressed patients has not been adequately studied. Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking RemeronSolTab. Drug Interactions As with other drugs, the potential for interaction by a variety of mechanisms (e.g., pharmacodynamic, pharmacokinetic inhibition or enhancement, etc.) is a possibility (see CLINICAL PHARMACOLOGY). Patients typically experience paresthesia in the extremities or generalized in the body.

Go To...

• remeron anxiety disorder
• remeron for dementia
• remeron as sleep aid
• remeron recommended time
• when to take remeron

remeron with prozac

These studies have shown that mirtazapine acts as an antagonist at central presynaptic α2 adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. The data remeron with prozac that the above effects could possibly be mediated by non-genotoxic mechanisms, the relevance of which to humans is not known. Physical and Psychologic Dependence RemeronSolTab (mirtazapine) Orally Disintegrating Tablets have not been systematically studied in animals or humans for its potential remeron with prozac abuse, tolerance, or remeron with prozac dependence. If Remeron is taken with certain other drugs, the remeron with prozac of either could be increased, decreased, or altered. It is not known whether Remeron will remeron with prozac an unborn baby. Remeron SolTab Orally Disintegrating Tablets All medicines may cause side effects, but many people have no, or minor, side effects. 3. Never take Remeron with one of these drugs or within 14 days of discontinuing therapy with one of them; and allow at least 14 days between remeron with prozac Remeron and starting an MAO inhibitor. Examination of age and gender subsets of the population did not reveal any differential responsiveness on the basis of these subgroupings. PRINCIPAL DISPLAY PANEL - 15 mg Carton NDC 0052-0106-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 15 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by CIMA Labs Inc., Eden Prairie, MN 55344 PRINCIPAL DISPLAY PANEL - 30 mg Carton NDC 0052-0108-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 30 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by CIMA Labs Inc., Eden Prairie, MN 55344 PRINCIPAL DISPLAY PANEL - 45 mg Carton NDC 0052-0110-30 30 Tablets ONCE-A-DAY RemeronSolTab® (mirtazapine) Orally Disintegrating Tablets Rx only 45 mg Organon Manufactured for Organon USA Inc., Roseland, NJ 07068 by CIMA Labs Inc., Eden Prairie, MN 55344 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0106 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient remeron with prozac Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 15 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   MANNITOL   CELLULOSE, MICROCRYSTALLINE   POVIDONE   SODIUM BICARBONATE   SUCROSE   Product Characteristics Color WHITE Score no score Shape ROUND Size 16mm Flavor ORANGE Imprint Code T1Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0106-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0106-30) 2 0052-0106-93 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 2 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0106-93) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA remeron with prozac 05/14/2010 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0108 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 30 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   MANNITOL   CELLULOSE, MICROCRYSTALLINE   POVIDONE   SODIUM BICARBONATE   SUCROSE   Product Characteristics Color WHITE Score no score Shape ROUND Size 13mm Flavor ORANGE Imprint Code T2Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0108-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0108-30) 2 0052-0108-93 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 2 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0108-93) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021208 05/14/2010 RemeronSOLTAB  mirtazapine  tablet, orally disintegrating Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0052-0110 Route of Administration ORAL DEA Schedule      Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength MIRTAZAPINE (MIRTAZAPINE) MIRTAZAPINE 45 mg Inactive Ingredients Ingredient Name Strength ASPARTAME   CITRIC ACID MONOHYDRATE   CROSPOVIDONE   HYPROMELLOSE   MAGNESIUM STEARATE   MANNITOL remeron with prozac CELLULOSE, MICROCRYSTALLINE remeron with prozac POVIDONE   SODIUM BICARBONATE   SUCROSE   remeron with prozac Characteristics Color WHITE Score remeron with prozac score Shape ROUND Size 10mm Flavor ORANGE Imprint Code T4Z Contains      Packaging # NDC Package Description Multilevel Packaging 1 0052-0110-30 5 BLISTER PACK In 1 BOX contains a BLISTER PACK 1 6 TABLET In 1 BLISTER PACK This package is contained within the BOX (0052-0110-30) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date NDA NDA021208 05/14/2010 Labeler - Organon Pharmaceuticals USA (002152858) Establishment Name Address ID/FEI Operations NV ORGANON 402157499 MANUFACTURE Establishment Name Address ID/FEI Operations CIMA LABS 173625823 MANUFACTURE Revised: 06/2010Organon Pharmaceuticals USA Remeron Generic Name: Mirtazapine (mihr-TAZZ-uh-peen) Brand Name: Remeron Antidepressants may increase the risk of suicidal thoughts or actions in children, teenagers, and young adults. Hematologic and lymphatic side effects such as lymphadenopathy, leukopenia, anemia, petechiae, thrombocytopenia, lymphocytosis, and pancytopenia have been reported but are uncommon. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 4 weeks of treatment. Mirtazapine is a moderate peripheral α1 adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Nevertheless, the physician who elects to use Remeron for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see CLINICAL PHARMACOLOGY). Talk to your child's healthcare provider for more information. The mirtazapine dose may have to be decreased when concomitant treatment with cimetidine is started, or increased when cimetidine treatment is discontinued. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Do not take extra medicine to make up the missed dose. Check the label on the medicine for exact dosing instructions. Nonfasting triglyceride increases to greater than 20% above the normal upper limits have been reported in 15% of patients receiving mirtazapine in clinical trials. The cited figures, however, do provide the prescribing physician with some basis for estimating the relative contribution of drug and nondrug factors to the side-effect incidence rate in the population studied. In one small study, mirtazapine appeared to improve glucose tolerance by reducing cortisol secretion. Be sure to keep all doctor and lab appointments. Follow the directions on your prescription label. Take the regular tablet form of mirtazapine with water. To take mirtazapine orally disintegrating tablets (Remeron SolTab): Keep the tablet in its blister pack until you are ready to take the medicine. Nevertheless, the physician who elects to use Remeron for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient (see CLINICAL PHARMACOLOGY). Stopping an antidepressant medicine suddenly can cause other symptoms.